outbreak
novel
coronaviru
diseas
deepli
weaken
world
particularli
healthcar
system
respiratori
physician
part
firstlin
healthcar
provid
involv
fight
sever
acut
respiratori
syndrom
coronaviru
whose
effect
human
bodi
still
poorli
understood
addit
sever
lung
parenchym
damag
main
caus
diseas
sever
particular
interest
rais
regard
venou
thromboembol
vte
diseas
context
profus
scientif
inform
sometim
contradictori
realli
know
know
activ
coagul
pathway
ddimer
level
greater
ngml
associ
poor
prognosi
retrospect
analysi
report
larger
involv
coagul
pathway
endotheli
dysfunct
clot
lead
elabor
intern
guidanc
recognit
manag
coagulopathi
addit
preliminari
analysi
patholog
data
report
diffus
alveolar
damag
mark
inflamm
around
thrombot
microangiopathi
limit
pulmonari
small
vessel
final
parallel
biolog
data
high
frequenc
vte
event
report
patient
admit
icu
patient
hypothes
extrapol
data
first
propos
specif
risk
factor
vte
howev
admiss
acut
infect
whatev
pathogen
inflammatori
diseas
alreadi
known
vte
trigger
role
anticoagul
therapi
mainli
lowmolecular
weight
heparin
lmwh
potenti
therapi
patient
suggest
one
rememb
less
quarter
patient
receiv
thromboprophylaxi
despit
prescript
wide
recommend
adult
patient
admit
acut
infect
posit
effect
heparin
propos
author
may
rather
repres
neg
effect
lack
thromboprophylaxi
frail
patient
second
patient
sever
present
exampl
intens
care
unit
icu
high
risk
vte
report
despit
thromboprophylaxi
henc
despit
absenc
evid
scientif
societi
suggest
increas
dosag
lmwh
thromboprophylaxi
particularli
high
level
ddimer
final
although
mani
commun
alert
risk
vte
patient
frequenc
vte
patient
still
unknown
answer
question
need
first
deciph
timelin
patient
differenti
patient
admit
concomit
vte
develop
vte
hospit
stay
use
computer
tomographi
scan
ctpage
j
u
r
n
l
p
r
e
p
r
f
scan
drastic
increas
admiss
hospit
assess
probabl
sever
howev
data
publish
base
ctscan
without
inject
preclud
inform
pulmonari
embol
pe
preval
admiss
similarli
follow
recommend
french
societi
radiolog
spiral
ct
pulmonari
angiographi
use
case
respiratori
degrad
frequenc
pe
report
today
moreov
icu
patient
perform
spiral
ct
pulmonari
angiographi
alway
feasibl
due
sever
diseas
use
compress
ultrasound
cu
systemat
screen
propos
center
base
hypothes
next
step
provid
evidencebas
medicin
patient
first
need
epidemiolog
data
prospect
cohort
patient
admit
perform
pep
trial
copd
patient
systemat
assess
vte
admiss
report
vte
event
followup
may
help
us
determin
frequenc
vte
patient
predict
factor
second
need
better
understand
pathophysiolog
coagulopathi
order
better
discrimin
patient
higher
risk
vte
popul
third
need
assess
efficaci
safeti
increas
dose
lmwh
thromboprophylaxi
hospit
stay
efficaci
safeti
extend
thromboprophylaxi
hospit
discharg
use
exampl
direct
oral
anticoagul
fourth
need
determin
best
treatment
option
patient
vte
intern
riet
registri
recent
commun
inform
baselin
characterist
evolut
th
patient
collect
data
academ
registri
help
us
increas
knowledg
evolut
patient
vte
